$KNSA
Kiniksa Pharmaceuticals Ltd

2021 Q3 Form 10-Q Financial Statement

#000155837021014650 Filed on November 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q4 2020 Q3
Revenue $12.10M $0.00 $0.00
YoY Change
Cost Of Revenue $2.767M
YoY Change
Gross Profit $9.328M
YoY Change
Gross Profit Margin 77.12%
Selling, General & Admin $20.76M $15.50M $11.80M
YoY Change 75.94% 59.79% 39.96%
% of Gross Profit 222.55%
Research & Development $19.24M $37.40M $31.42M
YoY Change -38.78% 63.39% 42.72%
% of Gross Profit 206.22%
Depreciation & Amortization $373.0K $570.0K $649.0K
YoY Change -42.53% 0.0% 24.09%
% of Gross Profit 4.0%
Operating Expenses $40.00M $52.90M $43.22M
YoY Change -7.46% 62.37% 41.95%
Operating Profit -$30.67M -$43.22M
YoY Change -29.04% 41.95%
Interest Expense $5.000K $30.00K $50.00K
YoY Change -90.0% -97.35% -96.4%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$30.66M -$52.87M -$43.17M
YoY Change -28.97% 68.11% 48.55%
Income Tax -$118.0K $790.0K $667.0K
% Of Pretax Income
Net Earnings -$30.54M -$53.66M -$43.84M
YoY Change -30.32% 68.74% 62.01%
Net Earnings / Revenue -252.53%
Basic Earnings Per Share -$0.44
Diluted Earnings Per Share -$444.8K -$787.8K -$664.6K
COMMON SHARES
Basic Shares Outstanding 68.66M
Diluted Shares Outstanding 68.66M

Balance Sheet

Concept 2021 Q3 2020 Q4 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $200.2M $323.5M $364.4M
YoY Change -45.07% 38.6% 40.86%
Cash & Equivalents $190.2M $114.0M $85.87M
Short-Term Investments $10.00M $209.4M $278.5M
Other Short-Term Assets $8.499M $9.800M $14.00M
YoY Change -39.29% 19.51% 45.83%
Inventory $5.606M $0.00
Prepaid Expenses
Receivables $3.224M
Other Receivables $0.00
Total Short-Term Assets $217.5M $333.2M $378.4M
YoY Change -42.52% 37.92% 41.04%
LONG-TERM ASSETS
Property, Plant & Equipment $3.168M $4.051M $4.573M
YoY Change -30.72% -36.68% -46.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.551M $5.588M $48.00K
YoY Change 13547.92% 21.48% -99.0%
Total Long-Term Assets $35.35M $16.22M $6.000M
YoY Change 489.12% 25.63% -55.56%
TOTAL ASSETS
Total Short-Term Assets $217.5M $333.2M $378.4M
Total Long-Term Assets $35.35M $16.22M $6.000M
Total Assets $252.9M $349.5M $384.4M
YoY Change -34.22% 37.3% 36.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.649M $503.0K $3.925M
YoY Change -57.99% -91.16% -38.67%
Accrued Expenses $28.53M $29.20M $19.48M
YoY Change 46.49% 43.03% -7.7%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $34.43M $31.85M $24.89M
YoY Change 38.31% 14.43% -9.81%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $885.0K $805.0K $957.0K
YoY Change -7.52% 146.93% -58.39%
Total Long-Term Liabilities $885.0K $805.0K $957.0K
YoY Change -7.52% 146.93% -58.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $34.43M $31.85M $24.89M
Total Long-Term Liabilities $885.0K $805.0K $957.0K
Total Liabilities $38.81M $37.53M $25.90M
YoY Change 49.83% 28.92% -13.36%
SHAREHOLDERS EQUITY
Retained Earnings -$639.1M -$517.5M -$463.8M
YoY Change 37.78% 45.32%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $214.0M $311.9M $358.5M
YoY Change
Total Liabilities & Shareholders Equity $252.9M $349.5M $384.4M
YoY Change -34.22% 37.3% 36.41%

Cashflow Statement

Concept 2021 Q3 2020 Q4 2020 Q3
OPERATING ACTIVITIES
Net Income -$30.54M -$53.66M -$43.84M
YoY Change -30.32% 68.74% 62.01%
Depreciation, Depletion And Amortization $373.0K $570.0K $649.0K
YoY Change -42.53% 0.0% 24.09%
Cash From Operating Activities -$28.51M -$41.19M -$34.32M
YoY Change -16.93% 70.42% 17.25%
INVESTING ACTIVITIES
Capital Expenditures -$51.00K -$50.00K -$10.00K
YoY Change 410.0% -97.49% -97.73%
Acquisitions
YoY Change
Other Investing Activities $47.90M $68.70M -$149.7M
YoY Change -132.01% 1657.03% -1055.68%
Cash From Investing Activities $47.85M $68.65M -$149.7M
YoY Change -131.97% 3494.24% -1083.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.680M 720.0K 146.4M
YoY Change -98.17% 89.47% 292680.0%
NET CHANGE
Cash From Operating Activities -28.51M -41.19M -34.32M
Cash From Investing Activities 47.85M 68.65M -149.7M
Cash From Financing Activities 2.680M 720.0K 146.4M
Net Change In Cash 22.02M 28.18M -37.59M
YoY Change -158.58% -228.79% 168.31%
FREE CASH FLOW
Cash From Operating Activities -$28.51M -$41.19M -$34.32M
Capital Expenditures -$51.00K -$50.00K -$10.00K
Free Cash Flow -$28.46M -$41.14M -$34.31M
YoY Change -17.06% 85.48% 19.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q3 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q3 knsa Fair Value Assets Level1 To Level3 Transfers Amount
FairValueAssetsLevel1ToLevel3TransfersAmount
0
CY2020Q4 knsa Fair Value Assets Level1 To Level3 Transfers Amount
FairValueAssetsLevel1ToLevel3TransfersAmount
0
CY2021Q3 knsa Fair Value Assets Level2 To Level3 Transfers Amount
FairValueAssetsLevel2ToLevel3TransfersAmount
0
CY2020Q4 knsa Fair Value Assets Level2 To Level3 Transfers Amount
FairValueAssetsLevel2ToLevel3TransfersAmount
0
CY2021Q3 knsa Fair Value Assets Level3 To Level1 Transfers Amount
FairValueAssetsLevel3ToLevel1TransfersAmount
0
CY2020Q4 knsa Fair Value Assets Level3 To Level1 Transfers Amount
FairValueAssetsLevel3ToLevel1TransfersAmount
0
us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2021-01-31#ProductMember
us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2021-01-31#ProductMember
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2021-01-31#ProductMember
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2021Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2020Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q4 knsa Fair Value Assets Level3 To Level2 Transfers Amount
FairValueAssetsLevel3ToLevel2TransfersAmount
0
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2021-01-31#ProductMember
dei Entity Central Index Key
EntityCentralIndexKey
0001730430
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38492
dei Entity Registrant Name
EntityRegistrantName
Kiniksa Pharmaceuticals, Ltd.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
D0
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1327726
dei Entity Address Address Line1
EntityAddressAddressLine1
Clarendon House
dei Entity Address Address Line2
EntityAddressAddressLine2
2 Church Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Hamilton
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
HM11
dei Entity Address Country
EntityAddressCountry
BM
dei City Area Code
CityAreaCode
808
dei Local Phone Number
LocalPhoneNumber
451-3453
dei Security12b Title
Security12bTitle
Class A Common Shares
dei Trading Symbol
TradingSymbol
KNSA
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
190183000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
114038000
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
10000000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
209444000
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
210000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3224000
CY2021Q3 us-gaap Inventory Net
InventoryNet
5606000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8499000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9557000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
217512000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
333249000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3168000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4051000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6128000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6566000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6551000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5588000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
19500000
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
10000
CY2021Q3 us-gaap Assets
Assets
252859000
CY2020Q4 us-gaap Assets
Assets
349464000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1649000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
503000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
28528000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
29199000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3246000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2107000
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1004000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
37000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
34427000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
31846000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3499000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4878000
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
885000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
805000
CY2021Q3 us-gaap Liabilities
Liabilities
38811000
CY2020Q4 us-gaap Liabilities
Liabilities
37529000
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
853139000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-639064000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
829424000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-45000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-34000
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
49000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-517473000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
214048000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
311935000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
252859000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
349464000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12095000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19799000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2767000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5233000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19236000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31419000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
71864000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
74644000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20759000
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11799000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
63207000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
29821000
CY2021Q3 knsa Total Cost Of Revenue And Operating Expenses
TotalCostOfRevenueAndOperatingExpenses
42762000
CY2020Q3 knsa Total Cost Of Revenue And Operating Expenses
TotalCostOfRevenueAndOperatingExpenses
43218000
knsa Total Cost Of Revenue And Operating Expenses
TotalCostOfRevenueAndOperatingExpenses
140304000
knsa Total Cost Of Revenue And Operating Expenses
TotalCostOfRevenueAndOperatingExpenses
104465000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-30667000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-43218000
us-gaap Operating Income Loss
OperatingIncomeLoss
-120505000
us-gaap Operating Income Loss
OperatingIncomeLoss
-104465000
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
5000
us-gaap Investment Income Interest
InvestmentIncomeInterest
20000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1104000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30662000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-43169000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-120485000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-103361000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-118000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
667000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1106000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4363000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-30544000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-43836000
us-gaap Net Income Loss
NetIncomeLoss
-121591000
us-gaap Net Income Loss
NetIncomeLoss
-107724000
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.44
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.66
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.78
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.80
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
68662673
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
65958513
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
68444061
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
59754495
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-30544000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-43836000
us-gaap Net Income Loss
NetIncomeLoss
-121591000
us-gaap Net Income Loss
NetIncomeLoss
-107724000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-72000
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-11000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-27000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-72000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-11000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-27000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30616000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-43839000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-121602000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-107751000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
311935000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
1106000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7126000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
13000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-49484000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
270696000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
887000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5717000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
48000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-41563000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
235785000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
2680000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6199000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-72000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-30544000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
214048000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
225423000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2414000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4209000
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
207000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-26419000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
205834000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2936000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4851000
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-231000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-37469000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
250416000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
331000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5558000
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-43836000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-617000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
239000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4321000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1034000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5768000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3224000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5606000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1059000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1116000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1704000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
295000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-969000
knsa Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1700000
knsa Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1105000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
80000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
630000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-107414000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
358509000
us-gaap Profit Loss
ProfitLoss
-121591000
us-gaap Profit Loss
ProfitLoss
-107724000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1687000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1838000
us-gaap Share Based Compensation
ShareBasedCompensation
19042000
us-gaap Share Based Compensation
ShareBasedCompensation
14618000
knsa Noncash Lease Expense
NoncashLeaseExpense
1895000
knsa Noncash Lease Expense
NoncashLeaseExpense
761000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-95341000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
164000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
228000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
97460000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
344159000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
296300000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
252300000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
20000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
178676000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-92087000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
165725000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
55944000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
976000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
4673000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
5681000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4673000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
226374000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
75935000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
38946000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
114248000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47138000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
190183000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86084000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
859000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
482000
knsa Deferred Offering Costs Included In Accrued Expenses And Accounts Payable
DeferredOfferingCostsIncludedInAccruedExpensesAndAccountsPayable
154000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
8000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1462000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 36pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of the Company’s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions reflected in these consolidated financial statements include, but are not limited to, the recognition of revenue, the capitalization of inventory, the accrual for research and development expenses and the valuation of share-based awards. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates.</p>
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-639064000
us-gaap Net Income Loss
NetIncomeLoss
-121591000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-107414000
knsa Contractual Obligation Regulatory Milestone Paid
ContractualObligationRegulatoryMilestonePaid
20000000
CY2021Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
200183000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 36pt;">Concentrations of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents and short-term investments. At September 30, 2021 and December 31, 2020, substantially all of the Company’s cash, cash equivalents and short-term investments were held at two financial institutions. The Company generally maintains balances in various operating accounts at financial institutions that management believes to be of high credit quality, in amounts that may exceed federally insured limits. The Company has not experienced any losses related to its cash, cash equivalents and short-term investments and does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company is also subject to credit risk from the accounts receivable related to product revenue. Trade accounts receivable are recorded net of allowances for cash discounts associated with prompt payments from customers. All trade accounts receivable arise from product revenue in the United States due from the Company’s third party logistics provider. There were no material write-offs charged against the allowance for the nine months ended September 30, 2021.</p>
CY2021Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
0
CY2020Q4 us-gaap Cash Collateral For Borrowed Securities
CashCollateralForBorrowedSecurities
210000
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P20Y
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20000000
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
0
CY2020Q3 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
0
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
0
CY2021Q3 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
0
CY2020Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
0
CY2020Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
0
CY2021Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
0
CY2021Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
0
CY2021Q3 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020 knsa Number Of Securities Unrealized Loss Position
NumberOfSecuritiesUnrealizedLossPosition
17
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
107753000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19799000
knsa Product Revenue Provision For Contractual Adjustments
ProductRevenueProvisionForContractualAdjustments
1365000
knsa Product Revenue Provision For Government Rebates
ProductRevenueProvisionForGovernmentRebates
615000
knsa Product Revenue Provision For Product Returns
ProductRevenueProvisionForProductReturns
301000
knsa Product Revenue Provision For Reserves And Allowances
ProductRevenueProvisionForReservesAndAllowances
2281000
knsa Product Revenue Refunds On Contractual Adjustments
ProductRevenueRefundsOnContractualAdjustments
798000
knsa Product Revenue Refunds And Payments On Government Rebates
ProductRevenueRefundsAndPaymentsOnGovernmentRebates
110000
knsa Product Revenue Refunds On Product Returns
ProductRevenueRefundsOnProductReturns
236000
knsa Product Revenue Refunds And Credits For Reserves And Allowances
ProductRevenueRefundsAndCreditsForReservesAndAllowances
1144000
CY2021Q3 knsa Product Revenue Reserve For Contractual Adjustments
ProductRevenueReserveForContractualAdjustments
567000
CY2021Q3 knsa Product Revenue Reserve For Government Rebates
ProductRevenueReserveForGovernmentRebates
505000
CY2021Q3 knsa Product Revenue Reserve For Sales Returns
ProductRevenueReserveForSalesReturns
65000
CY2021Q3 knsa Product Revenue Reserves And Allowances
ProductRevenueReservesAndAllowances
1137000
knsa Product Revenue Provision For Specific Product Returns
ProductRevenueProvisionForSpecificProductReturns
236000
CY2021Q3 knsa Product Revenue Reserves And Allowances
ProductRevenueReservesAndAllowances
1137000
CY2020Q4 us-gaap Inventory Net
InventoryNet
0
CY2021Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4183000
CY2021Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1423000
CY2021Q3 us-gaap Inventory Net
InventoryNet
5606000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8781000
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8977000
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5809000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4730000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3168000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4051000
CY2021Q3 us-gaap Depreciation
Depreciation
373000
CY2020Q3 us-gaap Depreciation
Depreciation
649000
us-gaap Depreciation
Depreciation
1079000
us-gaap Depreciation
Depreciation
1838000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
20000000
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
500000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
19500000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1000000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1000000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1000000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
14250000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
19500000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
250000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1000000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1000000
CY2021Q3 knsa Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
17805000
CY2020Q4 knsa Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
16945000
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8354000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7704000
CY2021Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2048000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3988000
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
321000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
562000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
28528000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
29199000
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0093
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0036
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0098
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0056
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M26D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M20D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M15D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7509
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8258
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7619
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8102
CY2021Q3 us-gaap Inventory Net
InventoryNet
5606000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6199000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5558000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19042000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14618000
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
20000000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-30544000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-43836000
us-gaap Net Income Loss
NetIncomeLoss
-121591000
us-gaap Net Income Loss
NetIncomeLoss
-107724000
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
68662673
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
65958513
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
68444061
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
59754495
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.44
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.66
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.78
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.80
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10357635
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10439647
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
0
CY2020Q3 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
0
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
0
CY2021Q3 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
0
CY2020Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
0
CY2020Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
0
CY2021Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
0
CY2021Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
0
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-118000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1106000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
667000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4363000
CY2021Q3 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
45742000
CY2021Q3 knsa Purchase Commitment Obligation Due In Next Rolling Twelve Months
PurchaseCommitmentObligationDueInNextRollingTwelveMonths
32693000

Files In Submission

Name View Source Status
0001558370-21-014650-index-headers.html Edgar Link pending
0001558370-21-014650-index.html Edgar Link pending
0001558370-21-014650.txt Edgar Link pending
0001558370-21-014650-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
knsa-20210930.xsd Edgar Link pending
knsa-20210930x10q.htm Edgar Link pending
knsa-20210930x10q_htm.xml Edgar Link completed
knsa-20210930xex31d1.htm Edgar Link pending
knsa-20210930xex31d2.htm Edgar Link pending
knsa-20210930xex32d1.htm Edgar Link pending
knsa-20210930xex32d2.htm Edgar Link pending
knsa-20210930_cal.xml Edgar Link unprocessable
knsa-20210930_def.xml Edgar Link unprocessable
knsa-20210930_lab.xml Edgar Link unprocessable
knsa-20210930_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending